Previous 10 | Next 10 |
The following slide deck was published by Alkermes plc in conjunction with this event. For further details see: Alkermes (ALKS) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- Slideshow
Summary BMEZ’s portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. Lack of diversification makes BMEZ susceptible to sector-specific risk. It also has a relatively high expense ratio despite...
Summary Alkermes' planned spinoff of its oncology assets could establish a long-term compounder with interesting economics tied in. Financial details on the planned move are light, with further information set to be released early this year. The market has reacted well with the pric...
Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN , Dec. 28, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview ...
Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference PR Newswire DUBLIN , Nov. 30, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securiti...
Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference PR Newswire DUBLIN , Nov. 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Everc...
Alkermes to Participate in the Stifel Healthcare Conference PR Newswire DUBLIN , Nov. 8, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference ...
Piper Sandler has upgraded Alkermes ( NASDAQ: ALKS ) to overweight following news that the company plans to spin-off its oncology business , a move that would lead to a leaner cost structure to support a pure-play neuropsychiatry company. The firm upped its price targe...
The following slide deck was published by Alkermes plc in conjunction with their 2022 Q3 earnings call. For further details see: Alkermes plc 2022 Q3 - Results - Earnings Call Presentation
Alkermes plc (ALKS) Q3 2022 Earnings Conference Call November 02, 2022, 08:00 AM ET Company Participants Sandra Coombs - SVP, IR & Corporate Affairs Richard Pops - CEO Iain Brown - CFO Todd Nichols - CCO Conference Call Participants Umer Raffa...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...